Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivmecillinam with Amoxicillin/Clavulanic acid for Step Down Oral Therapy in Febrile ESBL UTI
2024-513294-41-00Phase 4Authorised
- Sponsor
- Region Skåne
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pivmecillinam and amoxicillin + clavulanate in urinary tract infection (UTI), Bacteremia and Enterobacterales infection, sponsored by Region Skåne. Primary endpoint: Clinical response at test of cure (TOC). Planned start Oct 2024; status: authorised.
02
Drugs
pivmecillinamamoxicillin + clavulanate
03
Conditions
urinary tract infection (UTI)BacteremiaEnterobacterales infection
Beyond the preview
Go deeper on 2024-513294-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513294-41-00.